Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1964 of 6351
-
Can a common arthritis drug ease hand pain? new study investigates
Disease control OngoingA placebo-controlled randomized controlled trial exploring the effect of methotrexate on pain, function and structural outcomes in erosive inflammatory hand osteoarthritis.
Phase 4 • Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Smart radiation aims to zap liver tumors with fewer side effects
Disease control Recruiting nowStereotactic body radiotherapy (SBRT) is an established local treatment method for patients with hepatic oligometastases. Liver metastases often occur in close proximity to radiosensitive organs at risk (OARs). This limits the possibility to apply sufficiently high doses needed f…
Phase 2 • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a smartphone app sharpen the mind in early psychosis?
Symptom relief OngoingThe purpose of this study is to perform a practice-based research project designed to assess whether cognition and motivated behavior in early psychosis can be addressed as key treatment goals within real-world settings by using a 12-week mobile intervention program. Participants…
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Real-World dupixent study tracks Long-Term relief for sinusitis and nasal polyps
Disease control OngoingThe primary objectives of the study are: * To longitudinally characterize the long-term effectiveness of DUPIXENT® through assessment of patient-reported symptoms, Health-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal polyposis (CRSwNP) and other ty…
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for kids with rare kidney diseases: drug trial aims to cut protein leak
Disease control Recruiting nowTo evaluate the safety, efficacy and tolerability of sparsentan oral suspension and tablets, and assess changes in proteinuria after once-daily dosing over 108 weeks.
Phase 2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study pokes at best fix for leaky heart valve in Blocked-Artery patients
Disease control OngoingIschemic mitral regurgitation (MR) and coronary artery disease is common and associated with significant morbidity and mortality. Ischemic MR has been traditionally treated surgically through either valve repair or replacement at the time of concomitant bypass grafting. Although …
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Mind-Controlled arm training shows promise for stroke recovery
Knowledge-focused CompletedNon-invasive brain-computer interface (BCI) technology is one of the new training approaches to achieve motor restoration through a closed-loop system from brain activity through event-related desynchronization (ERD) after motor imagery (MI) or movement attempt to peripheral feed…
Sponsor: The Hong Kong Polytechnic University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Could a common drug slow Alzheimer's? new study tests rapamycin
Disease control OngoingThis study will evaluate the safety, tolerability, and feasibility of 12 month oral rapamycin treatment in older adults with amnestic mild cognitive impairment (aMCI) and early stage Alzheimer's disease (AD).
Phase 2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Targeted drug shows promise for Hard-to-Treat lymphoma
Disease control CompletedThe goal of this clinical trial was to evaluate whether zanubrutinib can effectively treat adults with CD79B-mutant relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Participants received zanubrutinib as monotherapy, underwent regular disease assessments to evaluate …
Phase 2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could less radiation be better for some cancers?
Disease control Recruiting nowThis study will test whether reduced-dose radiotherapy is an effective treatment for metastatic tumors with an ATM mutation. The researchers want to find the lowest dose of radiation that would still be effective to treat these tumors.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a common steroid heal COVID-Damaged lungs?
Disease control CompletedIntroduction: The new coronavirus (SARS-CoV-2) is a virus with an intense capacity for dissemination and high mortality rate. The main cause of death is viral pneumonia, characterized as organizing pneumonia that responds to treatment with corticosteroids. After 1 month of the ac…
Phase 1 • Sponsor: University of Sao Paulo • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New oral drug shows promise for rare sun allergy conditions
Disease control OngoingTo evaluate the long-term safety and tolerability of oral dersimelagon.
Phase 3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Sep 10, 2026 08:00 UTC
-
Could a support program ease the side effects of breast cancer hormone therapy?
Symptom relief Recruiting nowTo compare the efficacy of the addition of a therapeutic education program combined with nursing phone follow-up, compared to conventional management alone, on the management of adverse events (AEs) related to adjuvant hormone therapy during the first year of treatment in patient…
Sponsor: Centre Hospitalier Emile Roux • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Could a tiny sensor spare newborns dozens of needle sticks?
Symptom relief CompletedHypoglycemia (low blood glucose) is a very common problem in newborns, and has been associated with poor neurodevelopment, cognition, and school performance. At-risk newborns (infants of diabetic mothers \[IDM\], large \[LGA\] and small \[SGA\] for gestational age infants, and la…
Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Can your own stem cells repair MS nerve damage? new trial aims to find out
Disease control OngoingThe primary objective of the study is to investigate neuroregenerative efficacy (proof of concept) of intrathecal treatment with autologous MSCs as measured by neurophysiological parameters in patients with progressive MS. Secondary objectives are to assess neuroregenerative eff…
Phase 1/2 • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Real-World data shows promise for kidney cancer drug combo
Disease control CompletedThe main purpose of this study is to expand knowledge on the effectiveness of Avelumab intravenous infusion in combination with Axitinib as the first-line therapy in participants with advanced renal-cell carcinoma (aRCC) in addition to the safety and tolerability under routine co…
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental combo targets Hard-to-Treat HER2 cancers
Disease control OngoingThe dose escalation phase of this trial identifies the safety, side effects and best dose of ceralasertib (AZD6738) when given in combination with trastuzumab deruxtecan (DS-8201a) in treating patients with solid tumors that have a change (mutation) in the HER2 gene or protein an…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for tough pancreatic cancer? early trial tests immune boosts
Disease control CompletedThis trial is designed to evaluate multiple clinical hypotheses and mechanistically-defined combinations to evaluate the safety and efficacy of first-line chemo-immunotherapy combinations in participants with metastatic pancreatic ductal adenocarcinoma (mPDAC).
Phase 1 • Sponsor: Cancer Insight, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Quick HCV treatment with peer support boosts cure rates for drug users
Disease control CompletedThis study is being done to compare two strategies to deliver HCV treatment to persons with hepatitis C virus (HCV) who also use drugs and are participating in an outpatient opioid treatment program (OTP). Participants will be randomized into one of two treatment groups: 1. Test…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for liver cancer patients: which procedure best prevents dangerous rebleeding?
Disease control OngoingSP by EUS-CYA improves clinical outcomes (eg, EV rebleeding) in patients with HCC and prior EV bleeding when compared with SP by EGD-VBL
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC